Science Explorer Interactive view Map
Company · Tarrytown · United States

Progenics Pharmaceuticals (United States)

progenics.comROR OpenAlex
Research works
104
▼ 22% vs 2013–17
Citations
6.2k
59.4 per fractional work
Top-10% rate
5.0%
record average 16.5%
Open access
36%
world 28%

Not ranked overall: Progenics Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 3.02× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 16.95× its world share, 4 worksImmunology and Micro…Neuroscience: 0.73× its world share, 0 worksNeuroscienceHealth Professions: 0.82× its world share, 0 worksHealth ProfessionsMedicine: 3.22× its world share, 15 worksMedicineSocial Sciences: 0.12× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 16.9×. Every wedge is a field page.

Who are the top researchers at Progenics Pharmaceuticals (United States)?

Ranked on the composite score, Nancy Stambler, Vivien Wong and Robert J. Israel lead among researchers whose main affiliation is Progenics Pharmaceuticals (United States).

  1. 1 Nancy Stambler United States · #284,698 worldwide 351 citations · 15 works
  2. 2 Vivien Wong United States · #596,837 worldwide 78 citations · 19 works
  3. 3 Robert J. Israel United States · #987,981 worldwide 33 citations · 19 works
All ranked researchers at Progenics Pharmaceuticals (United States)

Which keywords describe research at Progenics Pharmaceuticals (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Inflammation, Treatment, Diagnosis, Epidemiology, Inflammatory Diseases, Management, Regulatory T Cells and IL-33.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 24 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 24 words, with their numbers
  1. Inflammation6▲ 11×12 topics
  2. Epidemiology4▲ 4.3×9 topics
  3. Treatment4▲ 13×5 topics
  4. Diagnosis3▲ 14×7 topics
  5. Inflammatory Diseases3▲ 70×3 topics
  6. Management3▲ 16×4 topics
  7. Regulatory T Cells3▲ 109×3 topics
  8. IL-333▲ 634×1 topic
  9. Innate Lymphoid Cells3▲ 634×1 topic
  10. Children2▲ 34×1 topic
  11. Eosinophilic Esophagitis2▲ 301×1 topic
  12. Guidelines2▲ 17×2 topics
  13. Asthma2▲ 78×2 topics
  14. Immune Response2▲ 13×5 topics
  15. Allergic Diseases2▲ 114×1 topic
  16. Eosinophils2▲ 114×1 topic
  17. Genetics2▲ 9.7×2 topics
  18. Cell Death1▲ 24×2 topics
  19. Inflammasome1▲ 135×1 topic
  20. NLRP31▲ 135×1 topic
  21. Hematopoietic Stem Cells1▲ 56×3 topics
  22. Lymphoma1▲ 28×2 topics
  23. Immunotherapy1▲ 6.0×2 topics
  24. Tumor Microenvironment1▲ 9.5×4 topics

Which research topics does Progenics Pharmaceuticals (United States) publish most on?

By volume in 2022–2025: IL-33, ST2, and ILC Pathways, Eosinophilic Esophagitis, Asthma and respiratory diseases and Inflammasome and immune disorders.

IL-33, ST2, and ILC Path…3IL-33, ST2, and ILC Pathways: 3 fractional worksEosinophilic Esophagitis: 2 fractional worksAsthma and respiratory diseases: 2 fractional worksInflammasome and immune disorders: 1 fractional worksChronic Obstructive Pulmonary Disease (COPD) Research: 1 fractional worksRNA modifications and ca…1RNA modifications and cancer: 1 fractional worksCAR-T cell therapy research: 1 fractional worksHematopoietic Stem Cell Transplantation: 1 fractional worksT-cell and B-cell Immunology: 1 fractional worksCancer Immunotherapy and Biomarkers: 1 fractional works
ImmunologySurgeryPhysiologyMolecular Biology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 IL-33, ST2, and ILC Pathways Immunology 3 works
  2. 2 Eosinophilic Esophagitis Surgery 2 works
  3. 3 Asthma and respiratory diseases Physiology 2 works
  4. 4 Inflammasome and immune disorders Molecular Biology 1 works
  5. 5 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 1 works
  6. 6 RNA modifications and cancer Molecular Biology 1 works
  7. 7 CAR-T cell therapy research Oncology 1 works
  8. 8 Hematopoietic Stem Cell Transplantation Hematology 1 works
  9. 9 T-cell and B-cell Immunology Immunology 1 works
  10. 10 Cancer Immunotherapy and Biomarkers Oncology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available36.1%not open63.9%

World: 28% of research is openly available.

with international co-authors19.1%domestic only80.9%

World: 19% is written across borders.

How has Progenics Pharmaceuticals (United States)'s research output changed?

Output in 2018–2022 was 22% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Tarrytown

All research institutions in Tarrytown

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.